The next Melanoma Community Forum will be hosted at UQ on Thursday 24th November both in-person and as a webinar, by the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID), on the topic of "The Future of Melanoma Screening".
The Alan Cooper Epiderm Lecture: TRANSFORMING THE EARLY DETECTION OF MELANOMA, was held on Friday 17 September 2021, at Customs House, Brisbane. This is an annual event hosted by the UQ Dermatology Research Centre.
University of Queensland researchers will lead the creation of a national blueprint for screening melanoma - one of Australia’s most common and deadly cancers.
Queenslanders could have skin cancer diagnosed earlier using world-first 3D scanning technology with the launch of the Australian Cancer Research Foundation Australian Centre of Excellence in Melanoma Imaging and Diagnosis.
A study involving 15,000 Australians which aims to develop a next-generation, standardised diagnosis for melanoma is one of 30 clinical trials and cohort studies to be funded through the National Health and Medical Research Council’s $74 million investment to find better ways to prevent, detect and treat disease.
The ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis has been named a part of a Monash University led national project to ensure research data remains both secure and FAIR (Findable, Accessible, Interoperable and Reusable) thanks to more than $950k from the Australian Research Data Commons (ARDC) and over $1.3m from other partners.
UQ Dermatology Research Centre Director Professor Peter Soyer recently appeared on Channel 7's The House of Wellness to discuss the early detection of melanoma with 3D whole body imaging machines with host Jo Stanley.
Artificial intelligence (AI) improved skin cancer diagnostic accuracy when used in collaboration with human clinical checks, an international study including University of Queensland researchers has found.
Melanoma affects 1 in 17 Australians, and other skin cancers 2 in 3 Australians, but setting up a formal screening program like we have for breast, cervical and bowel cancer is trickier than you might think.
